Identifying Ovarian Cancer Symptoms: Promoting Early Diagnosis, Treatment and Improved Outcomes Through Rapid Referral

Live Webinar via Zoom Meeting
12:00 - 1:00 PM ET

In women ages 35-74, ovarian cancer is the fifth leading cause of cancer-related mortality, accounting for more deaths than any other cancer of the female reproductive system. An estimated one woman in 78 will develop ovarian cancer during her lifetime. The American Cancer Society estimates that there will be 21,750 new cases of ovarian cancer diagnosed in 2020, and that more than 13,940 women will die from ovarian cancer this year.

When a woman is diagnosed and treated in the earliest stages, the five-year survival rate is over 90 percent, Due to ovarian cancer’s nonspecific symptoms and lack of early detection tests, about 15 percent of all cases are early, meaning stage I or II. If detected at stage III or higher, the five-year survival rate can be as low as 28 percent. Historically, ovarian cancer was called the silent killer because symptoms were not thought to develop until the chance of cure was poor. However, recent studies have proven this untrue. The following symptoms are more likely to occur in women with ovarian cancer than in women in the general population, even patients with early stage disease: bloating; pelvic or abdominal pain; difficulty eating or feeling full quickly; and urinary symptoms (urgency or frequency). As soon as ovarian cancer is diagnosed, rapid referral to a gynecologic oncologist can improve survival prognosis.

This webinar will illustrate the benefits of referral to gynecologic oncologists and will review risk factors including genetic syndromes, presentation in early and late stages, diagnostic evaluation, physical exam, and indicators for referral to a gynecologic oncologist.

Target Audience

Physicians and Physician Specialists (gynecologists, gastroenterologists), Physician Assistants, Nurse Practitioners, Registered Nurses, Medical Students, Residents, Fellows and other allied healthcare professionals engaged in the care of women.

Learning Objectives

After participating in this webcast, participants should be better able to: 

  • Identify signs and symptoms of ovarian cancer
  • Describe the incidence of ovarian cancer nationally and in Rhode Island
  • Identify survivorship and quality of life advantages for patients referred rapidly after diagnosis to gynecologic oncologists
  • Outline evidence-based guidelines for effective symptom workup and indication for referral to gynecologic oncologist
  • Identify risk factors including genetic syndromes
  • Understand the national protocols for genetic testing and counseling eligibility

Additional Information

AttachmentSize
Flyer_Ovarian Cancer Webcast - ag.pdf93.59 KB
Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
    The Warren Alpert Medical School of Brown University is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
  • 1.00 ANCC
    This continuing nursing education activity was approved by the Northeast Multistate Division, an accredited provider by the American Nurses Credentialing Center’s Commission on Accreditation.
  • 1.00 Attendance
    Participants will receive a Certificate of Attendance stating this program is designated for AMA PRA Category 1 Credit™. This credit is accepted by the AAPA and AANP.
  • 1.00 Social Work
    This activity has been approved by the NASW, Rhode Island Chapter.
Course opens: 
08/20/2020
Course expires: 
10/26/2021
Cost:
$0.00

Presenter

Paul A. DiSilvestro, MD
Professor of Obstetrics and Gynecology
Warren Alpert Medical School of Brown University
Director, Program in Women's Oncology 
Director, Division of Gynecologic Oncology 
Women & Infants Hospital
Providence, Rhode Island 

 

Planning Committee

Megan Daniel
Partnership to Reduce Cancer in RI

Linda Dziobek, RN
Survivor

Joseph Dziobek, MSW
Director, Partnership to Reduce Cancer in RI

Norma Hardy, MEd, CHES
Survivor

Donna MacDonald, RN, OCN, CCM
Case Manager - Oncology, Women & Infants Hospital

Jennifer Maloney
Office of Continuing Medical Education
Warren Alpert Medical School of Brown University 

Diane C. Martins, PhD, RN
University of Rhode Island College of Nursing

Matthew Oliver, MD
Women & Infants Hospital of RI

Jennifer Scalia Wilbur, MS
Program in Women's Oncology, Cancer Genetics and Prevention Program
Women & Infants Hospital

C. Kelly Smith, MSW
Comprehensive Cancer Control Program, RI Department of Health

Maria Sullivan
Director, Office of Continuing Medical Education
Warren Alpert Medical School of Brown University 

Siana Wood, RN, BSN, CDOE
Nurse Planner, Office of Continuing Medical Education
Warren Alpert Medical School of Brown University
 

 

 

 

 

The Warren Alpert Medical School of Brown University is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. 

The above program has been approved in accordance with the Regulations of the Rhode Island Social Work Board of Licensure.

This nursing continuing professional development activity was approved by the Northeast Multistate Division, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. 

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
    The Warren Alpert Medical School of Brown University is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
  • 1.00 ANCC
    This continuing nursing education activity was approved by the Northeast Multistate Division, an accredited provider by the American Nurses Credentialing Center’s Commission on Accreditation.
  • 1.00 Attendance
    Participants will receive a Certificate of Attendance stating this program is designated for AMA PRA Category 1 Credit™. This credit is accepted by the AAPA and AANP.
  • 1.00 Social Work
    This activity has been approved by the NASW, Rhode Island Chapter.

Price

Cost:
$0.00
Please login or register to take this course.

This is a live webinar hosted via the Zoom Meeting platform.

Once registered, you will receive an email confirmation with Zoom meeting access instructions.